Zynex Inc (NASDAQ:ZYXI) has announced a new partnership with Veterans Affairs Medical Centers (VAMCs) across the United States, a significant opportunity to expand the reach of its noninvasive medical devices for pain management and rehabilitation.
This collaboration provides an opportunity to expand sales of Zynex’s pain management solutions within the largest healthcare network in the US, which serves over 9 million enrolled veterans annually and accounts for more than $112 billion in annual healthcare spending.
Currently, less than 1% of Zynex's sales come from VAMCs, the company said.
Zynex will work closely with healthcare providers within the VA and Military Treatment Facility networks to offer its full suite of pain management solutions, designed to enhance patient outcomes and meet the unique needs of service members and their families.
"Our partnership to do business with the VA represents a significant milestone in expanding access to non-opioid pain management solutions for those who have served our country," Zynex CEO Thomas Sandgaard said.
"Working with the VA provides us with access to the largest healthcare network in the United States and we are honored to help enhance the quality of care for veterans nationwide."